Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)

Memorial Sloan Kettering Cancer Center · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
primary central nervous system (cns) lymphoma, secondary central nervous system lymphoma, mb-cart19.1 cellular therapy, relapsed/refractory, clinimacs prodigy device, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 857317
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.